pkan | Pantothenate kinase-associated neurodegeneration

Keyword	CPC	PCC	Volume	Score	Length of keyword
pkan	1.65	1	2038	37	4

Keyword	CPC	PCC	Volume	Score
pkan	1.08	0.6	1590	79
pkan disease	1.62	0.9	2900	69
planet fitness	1.93	1	6634	7
planned parenthood	1.3	0.8	9009	50
planet	1.71	0.8	2654	69
planner	1.66	0.1	3853	86
pikant	0.35	0.3	252	15
pkanalix	1.92	0.9	7189	52
planning center	0.89	0.8	619	5
pkan mri	0.16	0.7	3560	78
plans	0.21	0.6	8829	69
planting	1.63	0.9	7257	36
pkan pathway	0.17	0.3	5621	55
planning	1.29	0.4	382	72
planity	0.45	0.1	4849	52
pkan syndrome	1.39	0.8	6831	57
pk ankkuri	1.88	0.7	3262	85
pkan radiology	0.15	0.4	5602	54
pkan disease life expectancy	1.11	0.7	9524	28
plants	1.27	0.4	5377	2

Search Results related to pkan on Search Engine

Pantothenate kinase-associated neurodegeneration - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Pantothenate_kinase-associated_neurodegeneration

WebPantothenate kinase-associated neurodegeneration (PKAN), formerly called Hallervorden–Spatz syndrome, is a genetic degenerative disease of the brain that can lead to parkinsonism, dystonia, dementia, and ultimately death. Neurodegeneration in PKAN is accompanied by an excess of iron that progressively builds up in the brain.

DA: 13 PA: 11 MOZ Rank: 77

Pantothenate kinase-associated neurodegeneration
nih.gov

https://rarediseases.info.nih.gov/diseases/6564/pantothenate-kinase-associated-neurodegeneration/

WebDisease at a Glance. Summary. Pantothenate kinase-associated neurodegeneration (PKAN) is a rare disease characterized by a progressive degeneration of the nervous system (neurodegenerative disorder) and buildup of iron in the brain. PKAN is usually classified into two forms: classic and atypical.

DA: 44 PA: 79 MOZ Rank: 98

Pantothenate Kinase-Associated Neurodegeneration
rarediseases.org

https://rarediseases.org/rare-diseases/pantothenate-kinase-associated-neurodegeneration/

WebSep 10, 2019 · Disease Overview. Summary. Pantothenate kinase-associated neurodegeneration (PKAN), formerly called Hallervorden-Spatz syndrome, is a rare, inherited neurological movement disorder characterized by the progressive degeneration of specific regions in the central nervous system (neurodegenerative disorder).

DA: 13 PA: 19 MOZ Rank: 37

Pantothenate Kinase-Associated Neurodegeneration
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK1490/

WebAug 13, 2002 · Clinical characteristics. Pantothenate kinase-associated neurodegeneration (PKAN) is a type of neurodegeneration with brain iron accumulation (NBIA). The phenotypic spectrum of PKAN includes classic PKAN and atypical PKAN. Classic PKAN is characterized by early-childhood onset of progressive dystonia, …

DA: 17 PA: 19 MOZ Rank: 23

PKAN - NBIA Disorders Association
nbiadisorders.org

https://www.nbiadisorders.org/about-nbia/pkan

WebPantothenate Kinase-Associated Neurodegeneration is one of the most common forms of NBIA. Approximately 30-35% of the NBIA population has PKAN. It is caused by mutations in the PANK2 gene on chromosome 20. This gene provides the instruction for making an enzyme called pantothenate kinase.

DA: 21 PA: 98 MOZ Rank: 52

PKAN – United Brain Association
unitedbrainassociation.org

https://unitedbrainassociation.org/brain-resources/pkan/

WebPantothenate kinase-associated neurodegeneration (PKAN) is a neurological disorder in which iron accumulates in the brain and causes progressive damage to brain cells. Early symptoms of PKAN are movement difficulties that worsen over time, followed by other neurological symptoms.

DA: 91 PA: 17 MOZ Rank: 63

Pantothenate kinase-associated neurodegeneration - MedlinePlus
medlineplus.gov

https://medlineplus.gov/genetics/condition/pantothenate-kinase-associated-neurodegeneration/

WebPantothenate kinase-associated neurodegeneration (formerly called Hallervorden-Spatz syndrome) is a disorder of the nervous system. Explore symptoms, inheritance, genetics of this condition.

DA: 38 PA: 2 MOZ Rank: 56

Pantothenate Kinase-Associated Neurodegeneration (PKAN)
medscape.com

https://emedicine.medscape.com/article/1150519-overview

WebOct 5, 2023 · Pantothenate kinase-associated neurodegeneration (PKAN), formerly called Hallervorden-Spatz Disease (HSD), is a rare disorder characterized by progressive extrapyramidal dysfunction...

DA: 64 PA: 60 MOZ Rank: 10

Pantothenate kinase-associated neurodegeneration: Clinical …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937219/

WebMar 3, 2018 · Pantothenate Kinase-Associated Neurodegeneration (PKAN) is an autosomal recessive disorder characterized by a mutation in the PANK 2 gene. The clinical presentation may range from only speech disorder to severe generalized dystonia, spasticity, Visual loss, dysphagia and dementia.

DA: 90 PA: 38 MOZ Rank: 21

Diagnostic and clinical experience of patients with pantothenate …
biomedcentral.com

https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1142-1

WebJul 12, 2019 · Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive neurodegenerative disorder with brain iron accumulation (NBIA). To assess PKAN diagnostic pathway, history, and burden across the spectrum of PKAN severity from patient and/or caregiver perspectives.

DA: 95 PA: 40 MOZ Rank: 9